Skip to main content
Year archive

IMMUTEP LIMITED — 2026 filings

All 29 regulatory filings released by IMMUTEP LIMITED (IMM) in 2026, sourced directly from the official regulator.

29 Filings
2026 Period
2026 filings (29)
Filing Released Lang
Ceasing to be a substantial holder 13 pages 1.1MB
Major Shareholding Notification
2026-05-10 English
Immutep Quarterly Activities Report and Appendix 4C 10 pages 489.1KB
Interim / Quarterly Report
2026-04-29 English
Immutep Receives Nasdaq Notice of Bid Price Deficiency 2 pages 110.1KB
Regulatory Filings
2026-04-29 English
Change in substantial holding 32 pages 1.8MB
Major Shareholding Notification
2026-04-26 English
Change in substantial holding 6 pages 355.3KB
Major Shareholding Notification
2026-04-26 English
Change in substantial holding 22 pages 1.0MB
Major Shareholding Notification
2026-04-22 English
Abstract on Efti accepted for presentation at ASCO 2026 2 pages 137.0KB
Regulatory Filings
2026-04-21 English
Change in substantial holding 19 pages 1.2MB
Major Shareholding Notification
2026-04-16 English
Immutep receives FDA ODD for Efti in Soft Tissue Sarcoma 2 pages 184.5KB
Regulatory Filings
2026-04-14 English
Change in substantial holding 19 pages 887.2KB
Major Shareholding Notification
2026-04-12 English
Change in substantial holding 21 pages 1.3MB
Major Shareholding Notification
2026-04-09 English
Immutep Investor Update 8 pages 436.2KB
Investor Presentation
2026-04-07 English
Change in substantial holding 6 pages 329.1KB
Major Shareholding Notification
2026-03-19 English
Change in substantial holding 19 pages 957.4KB
Major Shareholding Notification
2026-03-19 English
Change in substantial holding 20 pages 1.3MB
Major Shareholding Notification
2026-03-18 English
Change in substantial holding 6 pages 327.2KB
Major Shareholding Notification
2026-03-18 English
Update on Phase I Study of IMP761 for Autoimmune Diseases 2 pages 279.8KB
Regulatory Filings
2026-03-18 English
Ceasing to be a substantial holder 3 pages 186.9KB
Major Shareholding Notification
2026-03-17 English
Change in substantial holding 6 pages 331.1KB
Major Shareholding Notification
2026-03-16 English
Becoming a substantial holder 12 pages 308.1KB
Major Shareholding Notification
2026-03-16 English
TACTI-004 to be discontinued following futility analysis 2 pages 117.4KB
Regulatory Filings
2026-03-12 English
Reinstatement to Quotation 1 page 120.7KB
Regulatory Filings
2026-03-12 English
Suspension from Quotation 2 pages 443.6KB
Regulatory Filings
2026-03-10 English
Trading Halt 2 pages 441.0KB
Regulatory Filings
2026-03-05 English
Half Yearly Report and Accounts 32 pages 1.5MB
Interim / Quarterly Report
2026-02-24 English
Change in substantial holding 11 pages 1.2MB
Major Shareholding Notification
2026-02-10 English
Immutep Achieves 50% Enrolment in Global TACTI-004-1L NSCLC 2 pages 156.7KB
Capital/Financing Update
2026-02-05 English
Change in substantial holding 20 pages 1.4MB
Major Shareholding Notification
2026-02-04 English
Immutep Quarterly Activities Report and Appendix 4C 12 pages 531.8KB
Interim / Quarterly Report
2026-01-28 English